A year after enduring a stinging FDA rejection, the Medicines Company convinced regulators to change their minds on the blood-thinning cangrelor, winning approval to treat a smaller group of patients after years of development.

…read more

Source: Medicines Co. finally wins an FDA nod for the clot-busting cangrelor


0 No comments